tamiflu sales dropped, page-6

cpg

i hope you are wrong, i value your view point but whilst we are thinking out loud , my belief is that relenza sales would have increased, be it only for the quarter, why else would production in china and elsewhere be ramped up even to fill outstanding orders ?
they may diminish later but we don't know the backlog and the intent of governments.
i bet that japan has switched to relenza albeit to late and stockpiles now filled.
we'll know soon enough !
plenty of other activity and upside for BTA

undervalued by miles